SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-013524
Filing Date
2018-12-04
Accepted
2018-12-04 07:36:58
Documents
3
Period of Report
2018-12-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v120418_8k.htm 8-K 23915
2 EXHIBIT 99.1 v120318_ex991.htm EX-99.1 17038
3 EXHIBIT 99.2 v120418_ex992.htm EX-99.2 16164
  Complete submission text file 0001654954-18-013524.txt   58515
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 181215394
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences